Porcine Vaccines Market (Disease Indication Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr 2018| TMR465A| Transparency

Report Highlights

Porcine Vaccines Market - Overview

This report on the porcine vaccines market analyzes the current and future scenario of the global market. Increase in the prevalence of diseases among swine, technological advancements of RNA strand methodology, and cultivation of pigs to raise standards of living are likely to drive the global porcine vaccines market during the forecast period. Increase in the number of trading facilities for live hogs/pigs, rise in the demand for pork meat, and innovations through clinical research activities are some of the factors expected to drive the global porcine vaccines market during the forecast period.

This report on the global porcine vaccines market comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the market with respect to segments based on disease indication, technology, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porter’s five forces analysis to help understand the competition landscape of the market. This section also provides market attractiveness analysis, in terms of country, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competition scenario in the global porcine vaccines market.

Based on technology, the porcine vaccines market has been segmented into inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. These market segments have been extensively analyzed based on increase in the demand for treatment of diseases such as PED, PRRS, and PCVAD. Surging demand for disease-free pork meat and increasing awareness for treating cultivated pigs are driving the technology segments of the market. Different types of end-users utilize porcine vaccines to treat swine diseases. Among end-users, the hog production farms segment holds a major share, followed by the veterinary hospitals segment. The market size (in terms of US$ Mn) and forecast for each segment have been provided for the period from 2015 to 2025. The report also provides the compounded annual growth rate (CAGR %) for each segment for the period from 2017 to 2025, considering 2016 as the base year.

Based on disease indication, the market has been segmented into diarrhoea, swine influenza, porcine reproductive and respiratory syndrome (PRRS), porcine circovirus associated disease (PCVAD), and others. Diarrhoea is the most widespread disease among pigs across the world. Porcine epidemic diarrhea virus (PEDV) hit the U.S. in 2013 and spread to Canada in 2014, which infected piglets. It had 80%–100% mortality rate. The above-mentioned segments have been analyzed based on available approved products, their cost-effectiveness, and preference by veterinarians for treating swine with various disease indications. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global porcine vaccines market has been categorized into five major regions and key countries/sub-regions in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competition scenario in the market in these regions.

The report also profiles major players in the global porcine vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report are Bayer AG., Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company), Merck & Co., Inc., Vetoquinol, and Zoetis Inc.

The global porcine vaccines market has been segmented as below:

Global Porcine Vaccines Market, by Disease Indication, 2015–2025
Diarrhea
Swine Influenza
Arthritis
Bordetella Rhinitis
Porcine Reproductive and Respiratory Syndrome (PRRS)
Porcine Circovirus Associated Disease (PCVAD)
Others (CHRS, Leptospirosis, etc.)

Global Porcine Vaccines Market, by Technology, 2015–2025
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines

Global Porcine Vaccines Market, by End-user, 2015–2025
Veterinary Hospitals
Hog Production Farms

Global Porcine Vaccines Market, by Geography, 2015–2025
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia

Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand

Rest of Asia Pacific
Latin America
Brazil
Mexico

Rest of Latin America
Middle East & Africa
South Africa

Rest of Middle East & Africa

  • Table 1 : Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
  • Table 2 : Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 3 : Global Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 4 : Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 5 : North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 6 : North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
  • Table 7 : North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 8 : North America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 9 : Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 10 : Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
  • Table 11 : Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 12 : Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 13 : Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 14 : Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
  • Table 15 : Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 16 : Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 17 : Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 18 : Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
  • Table 19 : Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 20 : Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 21 : Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 22 : Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
  • Table 23 : Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
  • Table 24 : Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Figure 1 : Global Porcine Vaccines Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 2 : Global Porcine Vaccines Market Value Share, by Technology (2016)
  • Figure 3 : Global Porcine Vaccines Market Value Share, by Region (2016)
  • Figure 4 : Global Porcine Vaccines Market Value Share, by End-user (2016)
  • Figure 5 : Global Porcine Vaccines Market Value Share, by Disease Indication (2016)
  • Figure 6 : Global Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
  • Figure 7 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inactivated Vaccines, 2015–2025
  • Figure 8 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Live Attenuated Vaccines, 2015–2025
  • Figure 9 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Toxoid Vaccines, 2015–2025
  • Figure 10 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Recombinant Vaccines, 2015–2025
  • Figure 11 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Conjugate Vaccines, 2015–2025
  • Figure 12 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by DNA Vaccines, 2015–2025
  • Figure 13 : Global Porcine Vaccines Market Attractiveness, by Technology, 2017–2025
  • Figure 14 : Global Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
  • Figure 15 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diarrhea, 2015–2025
  • Figure 16 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Swine Influenza, 2015–2025
  • Figure 17 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Arthritis, 2015–2025
  • Figure 18 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bordetella Rhinitis, 2015–2025
  • Figure 19 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PRRS, 2015–2025
  • Figure 20 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PCVAD, 2015–2025
  • Figure 21 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
  • Figure 22 : Global Porcine Vaccines Market Attractiveness, by Disease Indication, 2017–2025
  • Figure 23 : Global Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
  • Figure 24 : Global Porcine Vaccines Market Attractiveness, by End-user, 2017–2025
  • Figure 25 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Veterinary Hospitals, 2015–2025
  • Figure 26 : Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hog Production Farms, 2015–2025
  • Figure 27 : Global Porcine Vaccines Market Value Share, by Region, 2017 and 2025
  • Figure 28 : Global Porcine Vaccines Market Attractiveness, by Region, 2017–2025
  • Figure 29 : North America Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 30 : North America Porcine Vaccines Market Attractiveness, by Country, 2017–2025
  • Figure 31 : North America Porcine Vaccines Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 32 : North America Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
  • Figure 33 : North America Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
  • Figure 34 : North America Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
  • Figure 35 : North America Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
  • Figure 36 : North America Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
  • Figure 37 : North America Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 38 : North America Swine Production Level, by Top Countries/States
  • Figure 39 : Europe Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 40 : Europe Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 41 : Europe Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 42 : Europe Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
  • Figure 43 : Europe Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
  • Figure 44 : Europe Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
  • Figure 45 : Europe Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
  • Figure 46 : Europe Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
  • Figure 47 : Europe Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 48 : Europe Swine Production Level, by Top Countries/States
  • Figure 49 : Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 50 : Asia Pacific Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 51 : Asia Pacific Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 52 : Asia Pacific Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
  • Figure 53 : Asia Pacific Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
  • Figure 54 : Asia Pacific Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
  • Figure 55 : Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
  • Figure 56 : Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
  • Figure 57 : Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 58 : Asia Pacific Swine Production Level, by Top Countries/States
  • Figure 59 : Latin America Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 60 : Latin America Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 61 : Latin America Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 62 : Latin America Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
  • Figure 63 : Latin America Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
  • Figure 64 : Latin America Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
  • Figure 65 : Latin America Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
  • Figure 66 : Latin America Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
  • Figure 67 : Latin America Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 68 : Latin America Swine Production Level, by Top Countries/States
  • Figure 69 : Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 70 : Middle East & Africa Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 71 : Middle East & Africa Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 72 : Middle East & Africa Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
  • Figure 73 : Middle East & Africa Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
  • Figure 74 : Middle East & Africa Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
  • Figure 75 : Middle East & Africa Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
  • Figure 76 : Middle East & Africa Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
  • Figure 77 : Middle East & Africa Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 78 : Global Porcine Vaccines Market Share Analysis, by Company, 2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report